For the Inventor, By the Inventor

Enter assignee name

Philadelphia, PA, United States of America

Oncoceutics, Inc.

USPTO Granted Patents = 14

EPO Patents = 6

Forward Citations = 28

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Joshua E Allen (14 out of 24 patents)

Martin Stogniew (14 out of 49 patents)

Varun Vijay Prabhu (5 out of 5 patents)

4. Richard S Pottorf (5 out of 6 patents)

5. Bhaskara Rao Nallaganchu (5 out of 9 patents)

6. Gary Olson (5 out of 30 patents)

7. Yanjun Sun (3 out of 5 patents)

8. Gary L Olson (0 patent)

14 patents: Sort by Forward Citations

1. 12102639 - Imipridones for gliomas (2024-10-01),

2. 11976068 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2024-05-07),

3. 11116771 - G protein-coupled receptor (GPCR) modulation by imipridones (2021-09-14),

4. 10953014 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy (2021-03-23),

5. 10946022 - Imipridones for gliomas (2021-03-16),

6. 10456402 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy (2019-10-29),

7. 10369154 - Imipridones for gliomas (2019-08-06),

8. 10266533 - 7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2019-04-23),

9. 10172862 - Imipridones for gliomas (2019-01-08),

10. 10045992 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapy (2018-08-14),

11. 9845324 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2017-12-19),

12. 9688679 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy (2017-06-27),

13. 9376437 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy (2016-06-28),

14. 9265765 - 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy (2016-02-23),

Oncoceutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for treating cancer. Their research and development efforts are centered around the discovery and development of small molecules that target specific pathways involved in tumor growth and survival. By selectively targeting these pathways, Oncoceutics aims to deliver precise and effective treatments with reduced side effects. They have a strong pipeline of drug candidates and collaborate with leading academic institutions and pharmaceutical companies to advance cancer treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#68 in Philadelphia, PA

#792 in Pennsylvania

#21,640 in US

#40,937 in the World

Philadelphia, PA, United States of America

Oncoceutics, Inc.

Forward Citations = 28

7 inventors:

Joshua E Allen (14 out of 24 patents)

Martin Stogniew (14 out of 49 patents)

Varun Vijay Prabhu (5 out of 5 patents)

4. Richard S Pottorf (5 out of 6 patents)

5. Bhaskara Rao Nallaganchu (5 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…